Awareness and early detection can help make a big difference in health outcomes. That’s why we're partnering to expand Healthy Heart Africa. Learn more: https://lnkd.in/e-fWb5g9 #WhatScienceCanDo
AstraZeneca
Pharmaceutical Manufacturing
Cambridge, Cambridgeshire 3,075,500 followers
About us
We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio
- Website
-
http://www.astrazeneca.com
External link for AstraZeneca
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Cambridge, Cambridgeshire
- Type
- Public Company
- Specialties
- Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business
Locations
-
Primary
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge, Cambridgeshire CB2 0AA, GB
-
Astraallen
Sodertalje, Stockholm County 152 57, SE
Employees at AstraZeneca
Updates
-
What does it take for women executives to break down barriers? Overcoming a fear of failure is one of the many insights shared when AstraZeneca CFO Aradhana Sarin recently sat down with three inspiring women on our Board of Directors to discuss their experiences rising to the top of their profession. Thank you to Diana Layfield, Nazneen Rahman, and Sheri McCoy for participating in this thought-provoking discussion for Aradhana’s “In Conversation with…” podcast. Explore their stories here. https://learn.az/6044QQAvi
-
Identifying BRCA (BReast CAncer) gene pathogenic variants at point of diagnosis can help optimise breast cancer treatment, especially for patients who might exhibit aggressive disease. Understanding when to test is critical to support treatment and disease management. Let’s empower informed and shared decision-making in breast cancer care. #BreastCancer
-
Did you know policies focused on early detection, timely diagnosis and access to treatment has the potential to transform CKD care? Discover how in this POLITICO article: https://learn.az/6042QiYxq #ForKidneyHealth
-
The economic and health toll of the climate crisis is profound and rising rapidly. In a new report, the World Economic Forum Alliance of CEO Climate Leaders explore "The Cost of Climate Inaction" and make the business case for investments in adaptation and resilience, as well as decarbonisation. Discover the full report, including comments from our CEO Pascal Soriot, on how we’re investing in sustainable science and decarbonising our value chain to improve the health of people, society and the planet: https://learn.az/6042Q9mc6 #CEOClimateLeaders #NetZero #ClimateAction
-
We’re setting new standards in laboratory sustainability, becoming the first organisation to achieve the new My Green Lab 2.0 Certification. We have over 78 lab spaces certified in 15 countries, and 65 achieved the highest level of certification – Green. My Green Lab is a key measure of progress recognised by the United Nations Race to Zero campaign and underscores our commitment to sustainable science. #WhatScienceCanDo #GreenLabs #RacetoZero
-
#ASH2024 is a global stage for researchers to present the latest advances in haematology, which are made possible by combining diverse expertise and perspectives that challenge traditional ways of thinking. At AstraZeneca, we believe diversity fuels innovation. Having the opportunity to engage with many inspiring people at ASH further cemented the importance of our quest to advance gender equity across haematology and to continue driving scientific progress. Through our #HERmatology initiative, we are committed to breaking down barriers and increasing female representation in key haematology roles. Interested in joining the movement? Learn more here: https://learn.az/6045Q3fjU #WomenInScience #Haematology
-
Cardiovascular, renal, and metabolic (CVRM) diseases affect hundreds of millions globally. In the future, the prevalence of CVRM diseases is expected to increase. Those affected are often living with multiple CVRM conditions, increasing the complexity of care. And yet, these diseases are too often managed in isolation. In this STAT article, Mina Makar, RPh highlights the urgent need for a more integrated approach to CVRM care, alongside the scientific potential of combination therapies. Learn more: https://learn.az/6047Qr7a1
-
To improve global health outcomes, we need to build stable, resilient health systems with the right infrastructure, and ensure they meet people’s health needs today and tomorrow. Around the world, health systems are struggling, overburdened by ageing populations, the increase of chronic disease and the impacts of climate change and nature loss on health. Through our integrated approach to sustainability and focus on acting early, we’re committed to working with others to strengthen the delivery of care. Discover how we’re helping to accelerate change with the Partnership for Health System Sustainability and Resilience (PHSSR): https://learn.az/6047Q3buH!
-
We're unlocking the power of sustainable science through innovative digital solutions. By introducing electronic product information (ePI) across our medicines where regulations allow, we’re transforming the delivery of healthcare to become more resilient, equitable and net zero. Learn more about our approach to ePI: https://learn.az/6048Q1Zmw #WhatScienceCanDo